USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 165 filers reported holding USANA HEALTH SCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,378,925 | +90.2% | 53,719 | +60.9% | 0.00% | +100.0% |
Q4 2022 | $1,776,348 | +13.1% | 33,390 | +19.2% | 0.00% | 0.0% |
Q3 2022 | $1,570,000 | -40.1% | 28,017 | -22.7% | 0.00% | -33.3% |
Q2 2022 | $2,623,000 | +27.6% | 36,246 | +40.1% | 0.00% | +50.0% |
Q1 2022 | $2,056,000 | -21.7% | 25,875 | -0.3% | 0.00% | -33.3% |
Q4 2021 | $2,625,000 | +17.9% | 25,942 | +7.4% | 0.00% | +50.0% |
Q3 2021 | $2,227,000 | -32.6% | 24,157 | -25.1% | 0.00% | -50.0% |
Q2 2021 | $3,304,000 | +151.1% | 32,258 | +139.2% | 0.00% | +100.0% |
Q1 2021 | $1,316,000 | -10.2% | 13,485 | -29.1% | 0.00% | 0.0% |
Q4 2020 | $1,465,000 | +120.0% | 19,007 | +110.2% | 0.00% | +100.0% |
Q3 2020 | $666,000 | +19.6% | 9,041 | +19.2% | 0.00% | 0.0% |
Q2 2020 | $557,000 | -12.6% | 7,583 | -31.3% | 0.00% | 0.0% |
Q1 2020 | $637,000 | -54.4% | 11,032 | -37.9% | 0.00% | -50.0% |
Q4 2019 | $1,396,000 | +212.3% | 17,777 | +171.8% | 0.00% | +100.0% |
Q3 2019 | $447,000 | -86.5% | 6,540 | -83.5% | 0.00% | -85.7% |
Q1 2019 | $3,315,000 | -24.5% | 39,520 | +5.9% | 0.01% | -30.0% |
Q4 2018 | $4,392,000 | +605.0% | 37,309 | +622.5% | 0.01% | +900.0% |
Q3 2018 | $623,000 | -27.8% | 5,164 | -31.0% | 0.00% | -50.0% |
Q2 2018 | $863,000 | -19.6% | 7,486 | -40.1% | 0.00% | 0.0% |
Q1 2018 | $1,074,000 | -38.7% | 12,504 | -47.1% | 0.00% | -50.0% |
Q4 2017 | $1,751,000 | +74.1% | 23,651 | +35.6% | 0.00% | +33.3% |
Q3 2017 | $1,006,000 | -27.2% | 17,436 | -19.0% | 0.00% | -25.0% |
Q2 2017 | $1,381,000 | -4.4% | 21,538 | -14.1% | 0.00% | 0.0% |
Q1 2017 | $1,444,000 | +92.3% | 25,069 | +104.3% | 0.00% | +100.0% |
Q4 2016 | $751,000 | +69.5% | 12,269 | +282.9% | 0.00% | +100.0% |
Q3 2016 | $443,000 | -51.7% | 3,204 | -61.1% | 0.00% | -66.7% |
Q2 2016 | $917,000 | +206.7% | 8,230 | +252.0% | 0.00% | +200.0% |
Q4 2015 | $299,000 | -6.6% | 2,338 | -2.0% | 0.00% | 0.0% |
Q3 2015 | $320,000 | -6.2% | 2,385 | -4.5% | 0.00% | 0.0% |
Q2 2015 | $341,000 | +18.8% | 2,497 | -3.3% | 0.00% | 0.0% |
Q1 2015 | $287,000 | – | 2,583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 34,732 | $3,563,000 | 3.33% |
Matarin Capital Management, LLC | 28,322 | $2,905,554,000 | 1.28% |
Capital Impact Advisors, LLC | 21,373 | $2,193,000 | 1.03% |
USA FINANCIAL FORMULAS | 20,088 | $2,061,000 | 0.71% |
Camarda Financial Advisors, LLC | 8,951 | $918,000 | 0.58% |
Invictus RG Pte. Ltd. | 4,862 | $499,000 | 0.54% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 78,238 | $8,026,000 | 0.53% |
Wolf Group Capital Advisors | 6,696 | $687,000 | 0.50% |
RQSI Ltd | 3,937 | $404,000 | 0.38% |
CLARK ESTATES INC/NY | 23,759 | $2,437,000 | 0.36% |